Besides the well-known role of mutations in members of the MAPK pathways, such as BRAF and NRAS, an increasing number of studies have linked gene polymorphism and genetic variants to the members of the PI3K/AKT signaling pathway as susceptibility for cancer development [91,92,93]. The gene discussed is AKT1; the disease is cancer.